Jakobsen J, Flatmark A, Sodal G, Thorsby E
Postgrad Med J. 1976;52(5 Suppl):72-4.
Since January 1974, alternate cadaveric renal transplants were treated with antilymphocyte globulin (Behringwerke) om addotopm to prednisone and azathioprine. Thirty patients were treated in this way. 53% of patients receiving ALG had a functioning graft at six months as opposed to 40% in the control group. This difference is not significant. All other parameters were approximately equal in the two groups. No serious side effects of ALG treatment were observed.
自1974年1月起,对交替进行的尸体肾移植采用抗淋巴细胞球蛋白(贝林werke公司生产)加用泼尼松和硫唑嘌呤进行治疗。30例患者接受了这种治疗。接受抗淋巴细胞球蛋白治疗的患者中,53%在6个月时移植肾仍有功能,而对照组为40%。这种差异不显著。两组的所有其他参数大致相等。未观察到抗淋巴细胞球蛋白治疗的严重副作用。